Granules India Overview
- Founded
-
1984
- Status
-
Public
- Employees
-
5,427
- Stock Symbol
-
532482
- Investments
-
4
- Share Price
-
$3.90
- (As of Friday Closing)
Granules India General Information
Description
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.
Contact Information
Website
www.granulesindia.com
Formerly Known As
Triton Laboratories
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Primary Office
- 2nd Floor, 3rd Block
- My Home Hub, Madhapur
- Hyderabad, Telengana 500081
- India
+91 040 0000 0000
Granules India Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.90 | $3.88 | $2.91 - $5.05 | $963M | 248M | 88.5K | $0.22 |
Granules India Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 940,246 | 1,084,535 | 1,092,121 | 587,844 |
| Revenue | 517,144 | 500,241 | 429,575 | 358,229 |
| EBITDA | 95,913 | 96,046 | 116,004 | 84,923 |
| Net Income | 55,754 | 55,398 | 73,852 | 47,206 |
| Total Assets | 595,147 | 505,604 | 428,051 | |
| Total Debt | 0 | 145,897 | 115,624 | 118,284 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Granules India Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Granules India Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients,
Pharmaceuticals
Hyderabad, India
5,427
As of 2022
000.00
000000000000
000000
m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
000000000000000
Hyderabad, India
0000
As of 0000
00000
do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
000000000000000
Mumbai, India
0000
As of 0000
Add Comparison
Granules India Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neuland Laboratories | Corporation | Hyderabad, India | 0000 | |||
| 00000 00000 | Corporation | Mumbai, India | 0000 | |||
| 000000 000000 0000 | Corporation | Chennai, India | 0000 | 000.00 | 000000000 | 000.00 |
| 0000000 000000 | Private Equity-Backed | New Delhi, India | 00000 | 00000 | 0000000 0000 | 00000 |
| 00000 000000 | Corporation | Hyderabad, India | 0000 | 000.00 | 0000 | 000.00 |
Granules India Patents
Granules India Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180009790-A1 | An improved process for the preparation of hcv inhibitor | Abandoned | 24-Dec-2014 | 0000000000 | |
| US-10385006-B2 | Process for the preparation of amino alcohol derivatives or salts thereof | Active | 27-Oct-2014 | 0000000000 | |
| US-20170233329-A1 | Process for the preparation of amino alcohol derivatives or salts thereof | Granted | 27-Oct-2014 | 0000000000 | |
| CA-2946101-A1 | An improved process for the preparation of rifamycin derivatives | Abandoned | 19-Apr-2014 | 0000000000 | |
| EP-3134415-A2 | An improved process for the preparation of rifamycin derivatives | Withdrawn | 19-Apr-2014 | C07D498/22 |
Granules India Executive Team (11)
Granules India Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 00000000000 | Granules India | Founder, Chairman & Managing Director | 000 0000 |
Granules India Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Granules India Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Granules India Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 14-Jul-2016 | 000000000 | Pharmaceuticals | 0000000 0 | |
| 00000000-0000 | 20-Feb-2015 | 00000 0000 | 0000 | Pharmaceuticals | |
| 000000 000000 | 14-Feb-2014 | 0000000000 | 000.00 | Pharmaceuticals | 0000000 0 |
| Granules Biocause Pharmaceuticals | 06-Mar-2007 | Joint Venture | Drug Discovery |
Granules India Exits (2)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000-00000000 | 20-Feb-2015 | 00000 0000000 | 0000 | Completed |
|
| Granules Biocause Pharmaceuticals | 06-Mar-2007 | Joint Venture | Completed |
|